Page last updated: 2024-12-06

n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylamino-2-nitro-4-N',N'-bis(2-hydroxyethyl)aminobenzene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID17734
CHEMBL ID259863
CHEBI ID82333
SCHEMBL ID2467623
MeSH IDM0051377

Synonyms (45)

Synonym
hc blue no. 1 (purified)
2,2'-{[4-(methylamino)-3-nitrophenyl]imino}diethanol
2784-94-3
hc blue no. 1
1-methylamino-2-nitro-4-(bis-2-hydroxyethyl)aminobenzene
ethanol, 2,2'-((4-(methylamino)-3-nitrophenyl)imino)di-
n4,n4-bis(2-hydroxyethyl)-n1-methyl-2-nitro-p-phenylenediamine
n1,n1-bis(2-hydroxyethyl)-n4-methyl-3-nitro-p-phenylenediamine
einecs 220-495-9
n',n'-bis(2-hydroxyethyl)-n-methyl-2-nitro-p-phenylenediamine
2,2'-((4-(methylamino)-3-nitrophenyl)imino)bisethanol
ethanol, 2,2'-((4-(methylamino)-3-nitrophenyl)imino)bis-
hsdb 4182
brn 2134980
2,2'-((4-(methylamino)-3-nitrophenyl)imino)diethanol
nci-c04159
n-methyl-amino-2-nitro-4-n',n'-bis-(2-hydroxyethyl)-aminobenzene
hc blue number 1
p-phenylenediamine, n,n-bis(2-hydroxyethyl)-n'-methyl-2-nitro-
n,n-bis(2-hydroxyethyl)-n'-methyl-3-nitro-p-phenylenediamine
ccris 1362
hc blue no 1
hc blue 1
CHEMBL259863
chebi:82333 ,
2-[n-(2-hydroxyethyl)-4-(methylamino)-3-nitroanilino]ethanol
hc blue no.1
2,2'-[[4-(methylamino)-3-nitrophenyl]imino]bisethanol
C19247
n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene
unii-uh430igw0c
uh430igw0c ,
n-methylamino-2-nitro-4-n',n'-bis(2- hydroxyethyl)aminobenzene
n-methyl-n',n'-bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine
hc blue no. 1 [hsdb]
1-methylamino-2-nitro-4-n,n-(bis-.beta.-hydroxyethyl)aminobenzene
n1-methyl-n4,n4-bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine
n4,n4-bis(2'-hydroxyethyl)-n1-methyl-2-nitro-p-phenylenediamine
hc blue no. 1 [iarc]
SCHEMBL2467623
DTXSID6020191
Q27155882
hc azul 1
hc blu 1
hc bleu 1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID318681Anticarcinogenic activity in rat assessed as induction of tumors per day2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
QSAR modeling of the rodent carcinogenicity of nitrocompounds.
AID433903Hepatotoxicity in mouse assessed as carcinogenic potency2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's7 (50.00)18.2507
2000's2 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.58 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]